EAM
Eventide Asset Management Portfolio holdings
AUM
$5.71B
This Quarter Return
-0.92%
1 Year Return
+51.18%
3 Year Return
+209.28%
5 Year Return
+283.63%
10 Year Return
+1,480.39%
AUM
$5.02B
AUM Growth
+$5.02B
(-8.6%)
Cap. Flow
-$220M
Cap. Flow
% of AUM
-4.38%
Top 10 Holdings %
Top 10 Hldgs %
22.58%
Holding
260
New
56
Increased
99
Reduced
44
Closed
43
Top Buys
| 1 |
BBNX
Beta Bionics, Inc. Common Stock
BBNX
|
$60.3M |
| 2 |
Vulcan Materials
VMC
|
$39.2M |
| 3 |
United Rentals
URI
|
$38.7M |
| 4 |
Axon Enterprise
AXON
|
$35.4M |
| 5 |
Inspire Medical Systems
INSP
|
$28.9M |
Top Sells
| 1 |
Entegris
ENTG
|
$47.7M |
| 2 |
DT Midstream
DTM
|
$41.3M |
| 3 |
monday.com
MNDY
|
$40.3M |
| 4 |
Iron Mountain
IRM
|
$39.3M |
| 5 |
Workday
WDAY
|
$38.4M |
Sector Composition
| 1 | Healthcare | 38.88% |
| 2 | Technology | 18.67% |
| 3 | Industrials | 15.98% |
| 4 | Consumer Discretionary | 7.48% |
| 5 | Financials | 4.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
United Therapeutics
UTHR
$17.7B
| $14.6M | 0.29% |
47,241
-20,584
| -30% | -$6.35M |
|
102
Syndax Pharmaceuticals
SNDX
$1.39B
| $14.5M | 0.29% |
1,178,062
| – | – |
|
103
Fair Isaac
FICO
$36.5B
| $14.4M | 0.29% |
7,834
+66
| +0.8% | +$122K |
|
104
Kymera Therapeutics
KYMR
$3.1B
| $14.4M | 0.29% |
525,138
+69,410
| +15% | +$1.9M |
|
105
Acadia Pharmaceuticals
ACAD
$4.34B
| $14.2M | 0.28% |
852,845
| – | – |
|
106
Vital Farms
VITL
$2.2B
| $14.1M | 0.28% |
463,905
+170
| +0% | +$5.18K |
|
107
McCormick & Company Non-Voting
MKC
$18.7B
| $14.1M | 0.28% |
+171,051
| New | +$14.1M |
|
108
Sarepta Therapeutics
SRPT
$1.98B
| $13.7M | 0.27% |
214,374
-58,580
| -21% | -$3.74M |
|
109
Biohaven
BHVN
$1.71B
| $13.5M | 0.27% |
560,056
| – | – |
|
110
Chewy
CHWY
$16.8B
| $13.5M | 0.27% |
+413,875
| New | +$13.5M |
|
111
Xylem
XYL
$34B
| $13.2M | 0.26% |
+110,916
| New | +$13.2M |
|
112
Revolution Medicines
RVMD
$7.43B
| $13.2M | 0.26% |
372,229
| – | – |
|
113
Equity Lifestyle Properties
ELS
$11.7B
| $13.1M | 0.26% |
+195,783
| New | +$13.1M |
|
114
Rockwell Automation
ROK
$38.1B
| $13M | 0.26% |
+50,195
| New | +$13M |
|
115
Celcuity
CELC
$2.3B
| $12.8M | 0.25% |
1,265,653
| – | – |
|
116
IDEAYA Biosciences
IDYA
$2.26B
| $12.6M | 0.25% |
771,844
| – | – |
|
117
Edgewise Therapeutics
EWTX
$1.54B
| $12.5M | 0.25% |
+568,310
| New | +$12.5M |
|
118
Pool Corp
POOL
$11.4B
| $12.4M | 0.25% |
38,919
+801
| +2% | +$255K |
|
119
CDW
CDW
$21.4B
| $12.3M | 0.24% |
76,701
+1,550
| +2% | +$248K |
|
120
Geron
GERN
$893M
| $11.2M | 0.22% |
7,072,000
| – | – |
|
121
Avidity Biosciences
RNA
$6.12B
| $11.1M | 0.22% |
375,924
| – | – |
|
122
RLI Corp
RLI
$6.17B
| $10.3M | 0.21% |
128,776
+47,199
| +58% | -$2.76M |
|
123
Linde
LIN
$221B
| $10.3M | 0.21% |
22,177
+2,111
| +11% | +$981K |
|
124
Weave Communications
WEAV
$586M
| $10.3M | 0.21% |
928,642
-183,898
| -17% | -$2.04M |
|
125
S&P Global
SPGI
$165B
| $9.41M | 0.19% |
18,535
+913
| +5% | +$464K |
|